Have $3,000? Buying These 3 Stocks Now Just Might Be the Smartest Move You'll Ever MakeThe Motley Fool • 02/07/22
Vertex Pharmaceuticals: DCF Modeling Of Legacy CFTR Portfolio Supports A Long PositionSeeking Alpha • 01/30/22
Looking for a Growth Stock? 3 Reasons Why Vertex (VRTX) is a Solid ChoiceZacks Investment Research • 01/27/22
Vertex Pharmaceuticals Clocks 27% Growth In Product Revenues, Issues FY22 GuidanceBenzinga • 01/27/22
Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 01/27/22
Vertex Pharmaceuticals (VRTX) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 01/26/22